UPDATE: Bank Of America Downgrades Sagent Pharmaceuticals On Potential Near-Term Volatility

By: via Benzinga
In a report published Friday, Bank of America analyst Sumant S. Kulkarni downgraded the rating on Sagent Pharmaceuticals (NASDAQ: SGNT) ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.